CN119655753A - 用于检测和获取生物标志物的方法和装置 - Google Patents

用于检测和获取生物标志物的方法和装置 Download PDF

Info

Publication number
CN119655753A
CN119655753A CN202411870462.9A CN202411870462A CN119655753A CN 119655753 A CN119655753 A CN 119655753A CN 202411870462 A CN202411870462 A CN 202411870462A CN 119655753 A CN119655753 A CN 119655753A
Authority
CN
China
Prior art keywords
probes
microneedles
biomarker
microneedle
probe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202411870462.9A
Other languages
English (en)
Chinese (zh)
Inventor
塔希尔·A·玛穆德
图斌·J·迪克森
内蒂尔·A·玛穆德
佩特·卡佩克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Mindera Health
Original Assignee
Scripps Research Institute
Mindera Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute, Mindera Corp filed Critical Scripps Research Institute
Publication of CN119655753A publication Critical patent/CN119655753A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/02—Instruments for taking cell samples or for biopsy
    • A61B10/0233—Pointed or sharp biopsy instruments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14503—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
    • A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
    • A61B5/14514—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid using means for aiding extraction of interstitial fluid, e.g. microneedles or suction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150015—Source of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150015—Source of blood
    • A61B5/150022—Source of blood for capillary blood or interstitial fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150977—Arrays of piercing elements for simultaneous piercing
    • A61B5/150984—Microneedles or microblades
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/02—Devices for withdrawing samples
    • G01N1/04—Devices for withdrawing samples in the solid state, e.g. by cutting
    • G01N1/08—Devices for withdrawing samples in the solid state, e.g. by cutting involving an extracting tool, e.g. core bit
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A61B2010/008—Interstitial fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/04—Arrangements of multiple sensors of the same type
    • A61B2562/046—Arrangements of multiple sensors of the same type in a matrix array
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/685—Microneedles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2543/00—Reactions characterised by the reaction site, e.g. cell or chromosome
    • C12Q2543/10—Reactions characterised by the reaction site, e.g. cell or chromosome the purpose being "in situ" analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/16—Ophthalmology
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
CN202411870462.9A 2012-12-14 2013-12-13 用于检测和获取生物标志物的方法和装置 Pending CN119655753A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261737237P 2012-12-14 2012-12-14
US61/737,237 2012-12-14
CN201380065515.3A CN104853802B (zh) 2012-12-14 2013-12-13 用于检测和获取生物标志物的方法和装置
PCT/US2013/075187 WO2014093934A1 (en) 2012-12-14 2013-12-13 Methods and devices for detection and acquisition of biomarkers

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201380065515.3A Division CN104853802B (zh) 2012-12-14 2013-12-13 用于检测和获取生物标志物的方法和装置

Publications (1)

Publication Number Publication Date
CN119655753A true CN119655753A (zh) 2025-03-21

Family

ID=50935018

Family Applications (3)

Application Number Title Priority Date Filing Date
CN202411870462.9A Pending CN119655753A (zh) 2012-12-14 2013-12-13 用于检测和获取生物标志物的方法和装置
CN202111395029.0A Active CN114176586B (zh) 2012-12-14 2013-12-13 用于检测和获取生物标志物的方法和装置
CN201380065515.3A Active CN104853802B (zh) 2012-12-14 2013-12-13 用于检测和获取生物标志物的方法和装置

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN202111395029.0A Active CN114176586B (zh) 2012-12-14 2013-12-13 用于检测和获取生物标志物的方法和装置
CN201380065515.3A Active CN104853802B (zh) 2012-12-14 2013-12-13 用于检测和获取生物标志物的方法和装置

Country Status (8)

Country Link
US (3) US9540684B2 (https=)
EP (2) EP2931356B1 (https=)
JP (5) JP2016509471A (https=)
KR (4) KR20240091108A (https=)
CN (3) CN119655753A (https=)
AU (5) AU2013358890A1 (https=)
CA (1) CA2892587A1 (https=)
WO (1) WO2014093934A1 (https=)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
EP3360978A3 (en) 2009-05-07 2018-09-26 Veracyte, Inc. Methods for diagnosis of thyroid conditions
WO2014093934A1 (en) 2012-12-14 2014-06-19 Mindera Corporation Methods and devices for detection and acquisition of biomarkers
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
CA2951514C (en) 2014-06-18 2025-09-09 Clear Gene, Inc. METHODS, COMPOSITIONS AND DEVICES FOR THE RAPID ANALYSIS OF BIOLOGICAL MARKERS
US10321858B2 (en) * 2014-08-18 2019-06-18 Proteadx, Inc. Apparatus and methods for transdermal sensing of analytes in interstitial fluid and associated data transmission systems
US20170335396A1 (en) 2014-11-05 2017-11-23 Veracyte, Inc. Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data
WO2017007271A1 (ko) * 2015-07-09 2017-01-12 주식회사 넥스모스 앱타머 코팅된 마이크로니들 기반 진단용 피부 패치
GB201517373D0 (en) * 2015-10-01 2015-11-18 Ge Healthcare Uk Ltd Micro-Needle Sampling Device And Use Thereof
CA3008273A1 (en) 2015-12-18 2017-06-22 Clear Gene, Inc. Methods, compositions, kits and devices for rapid analysis of biological markers
JP6930986B2 (ja) * 2016-03-02 2021-09-01 ジェイ・ピィ・サイエンティフィック・リミテッドＪｐ Ｓｃｉｅｎｔｉｆｉｃ Ｌｉｍｉｔｅｄ サンプルから成分を抽出するための方法および装置
CN113481294B (zh) 2016-07-08 2024-03-12 花王株式会社 核酸样品的制备方法
EP3564672A4 (en) * 2016-12-28 2020-09-09 Nexmos Co., Ltd. PROCESS FOR MANUFACTURING A DIAGNOSTIC SKIN STAMP BASED ON MICRO-NEEDLES COATED WITH APTAMERS AND STAMP
JP2020522690A (ja) * 2017-06-02 2020-07-30 ベラサイト インコーポレイテッド 肺疾病の特定又はモニタリング方法及びシステム
US12275994B2 (en) 2017-06-22 2025-04-15 Clear Gene, Inc. Methods and compositions for the analysis of cancer biomarkers
WO2019089567A1 (en) 2017-10-30 2019-05-09 Massachusetts Institute Of Technology Layer-by-layer nanoparticles for cytokine therapy in cancer treatment
DE102018103215B3 (de) 2018-02-13 2019-08-14 Gna Biosolutions Gmbh Verfahren und Vorrichtung zur Extraktion einer Nukleinsäure aus einer Probenflüssigkeit
CA3090785A1 (en) 2018-02-14 2019-08-22 John Daniel Dobak Iii Novel gene classifiers and uses thereof in non-melanoma skin cancers
CN109459569A (zh) * 2018-07-28 2019-03-12 南昌大学 一种免血样肿瘤早期监测的方法
KR102239272B1 (ko) * 2018-11-20 2021-04-12 부산대학교 산학협력단 마이크로니들, 이를 포함하는 패치 및 이의 제조 방법
KR102187439B1 (ko) * 2019-01-30 2020-12-07 주식회사 라파스 마이크로니들 패취를 이용한 최소 침습적 피부 생체 검사 방법
KR102513569B1 (ko) * 2019-03-19 2023-03-24 한국생명공학연구원 전사 시스템 기반 고감도 센서
WO2021002984A1 (en) * 2019-05-30 2021-01-07 Massachusetts Institute Of Technology Peptide nucleic acid functionalized hydrogel microneedles for sampling and detection of interstitial fluid nucleic acids
WO2020251802A1 (en) * 2019-06-14 2020-12-17 Bio-Rad Laboratories, Inc. System and method for automated single cell processing and analyses
NL2024277B1 (en) * 2019-11-21 2021-08-11 Imcomet B V Interstitial fluid removal device
KR102122208B1 (ko) * 2020-04-07 2020-06-12 주식회사 라파스 마이크로니들 패치를 이용한 최소 침습적 아토피 피부염 검사 방법 및 마이크로니들 패치를 포함하는 최소 침습적 아토피 검사 키트
JP2023523952A (ja) 2020-04-28 2023-06-08 ティコナ・エルエルシー マイクロニードルアセンブリ
US20210380965A1 (en) * 2020-06-08 2021-12-09 North Carolina State University Microneedle-based rapid analyte extraction from plant and animal tissues and related methods and systems
US20230310633A1 (en) * 2020-06-26 2023-10-05 Allymab, Inc. Binding modulator
WO2022035075A1 (ko) * 2020-08-10 2022-02-17 주식회사 큐티스의 생명연구센터 마이크로니들 패치를 포함하는 최소 침습적 피부 상태 진단 키트
CN116782827A (zh) * 2020-11-30 2023-09-19 明德拉公司 微针装置和方法以及皮肤病状测定
AU2021390587A1 (en) * 2020-12-04 2023-03-30 Dermr Health Solutions Pty Ltd Minimally invasive skin sample collection apparatus
KR102836680B1 (ko) * 2021-01-26 2025-07-21 단국대학교 천안캠퍼스 산학협력단 진단 및 분석을 위한 마이크로니들 기반 통합 액체생검 마이크로 시스템
CN113985034A (zh) * 2021-10-28 2022-01-28 赵超超 一种编码微针贴片及其制备方法和应用
CN114113024B (zh) * 2021-12-20 2023-07-07 深圳大学 一种检测乳腺癌组织间隙液中标志物的微针及其制备方法
WO2023192004A2 (en) * 2022-03-30 2023-10-05 Inflammatix, Inc. Methods for diagnosing myocardial infarction
CN116497121B (zh) * 2023-04-23 2025-06-27 陕西创悦熙妍企业管理有限公司 一种基因检测试剂盒及其应用
KR102856481B1 (ko) * 2023-11-08 2025-09-09 경북대학교 산학협력단 자성 교반 소자를 이용한 마이크로니들 자동화 분석 장치 및 그 방법
WO2025105915A1 (ko) * 2023-11-13 2025-05-22 (주)시지바이오 마이크로니들 구조체 및 이의 조성물

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US6293925B1 (en) 1997-12-31 2001-09-25 Minimed Inc. Insertion device for an insertion set and method of using the same
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
AU6123899A (en) 1998-10-15 2000-05-01 Toyo Kohan Co. Ltd. Supports for immobilizing dna or the like
US6743211B1 (en) 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
US6256533B1 (en) 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
US6511463B1 (en) 1999-11-18 2003-01-28 Jds Uniphase Corporation Methods of fabricating microneedle arrays using sacrificial molds
US6692965B1 (en) * 1999-11-23 2004-02-17 Chromocell Corporation Isolation of living cells and preparation of cell lines based on detection and quantification of preselected cellular ribonucleic acid sequences
ES2253278T3 (es) 1999-12-10 2006-06-01 Alza Corporation Dispositivo y procedimiento para mejorar la perforacion cutanea con microprotuberancias.
MXPA02005765A (es) 1999-12-10 2003-01-28 Alza Corp Aparato de tratamiento de piel para el suministro de farmaco transdermico sostenido.
EP1127576A1 (de) * 2000-02-23 2001-08-29 Switch Biotech Aktiengesellschaft Verwendungen von NM23-Polypeptiden bei Haut- und Darmerkrankungen
KR100704528B1 (ko) 2000-04-04 2007-04-10 도요 고한 가부시키가이샤 표면 처리층이 형성된 슬라이드 글라스
US7078172B1 (en) 2000-08-08 2006-07-18 Toyo Kohan Co., Ltd. Substrate activation kit and method for detecting DNA and the like using the same
US6749575B2 (en) * 2001-08-20 2004-06-15 Alza Corporation Method for transdermal nucleic acid sampling
US6533949B1 (en) 2000-08-28 2003-03-18 Nanopass Ltd. Microneedle structure and production method therefor
PL360978A1 (en) 2000-10-13 2004-09-20 Alza Corporation Microblade array impact applicator
ATE416692T1 (de) 2000-10-13 2008-12-15 Alza Corp Mikronadelelementhalter für schlagapplikator
JP3605039B2 (ja) * 2001-01-09 2004-12-22 株式会社日立製作所 核酸マイクロアレイ、その製造方法及びそれを用いた核酸検出方法
WO2002072889A2 (en) * 2001-01-12 2002-09-19 Applera Corporation Methods and compositions for microarray control
US6663820B2 (en) 2001-03-14 2003-12-16 The Procter & Gamble Company Method of manufacturing microneedle structures using soft lithography and photolithography
WO2003016574A1 (en) * 2001-08-16 2003-02-27 Zhifeng Shao Analysis of gene expression profiles using sequential hybridization
US6881203B2 (en) 2001-09-05 2005-04-19 3M Innovative Properties Company Microneedle arrays and methods of manufacturing the same
AU2002343457A1 (en) 2001-09-28 2003-04-07 Biovalve Technologies, Inc. Switchable microneedle arrays and systems and methods relating to same
US20030211528A1 (en) * 2002-03-12 2003-11-13 Norman Iscove Exponential amplification of sub-picogram nucleic acid samples with retention of quantitative representation
AU2012213965B2 (en) * 2003-09-11 2015-10-22 Labrador Diagnostics Llc Medical device for analyte monitoring and drug delivery
WO2005052001A2 (en) * 2003-11-21 2005-06-09 Zymogenetics, Inc. Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation
US8551391B2 (en) 2004-02-17 2013-10-08 Avery Dennison Corporation Method of making microneedles
JP4202391B2 (ja) * 2004-03-17 2008-12-24 パナソニック株式会社 バイオチップの製造方法、プローブ溶液、および、バイオチップ
DK2995331T3 (da) 2004-09-10 2019-01-02 Becton Dickinson Co Rekonstitutonsinfusionsindretning og fremgangsmåde til rekostituering af et medikament
WO2006042328A2 (en) * 2004-10-12 2006-04-20 John Wayne Cancer Institute Treatment of cancer and compositions
TW200730825A (en) * 2005-10-21 2007-08-16 Genenews Inc Method and apparatus for correlating levels of biomarker products with disease
US8007999B2 (en) * 2006-05-10 2011-08-30 Theranos, Inc. Real-time detection of influenza virus
WO2007143669A2 (en) * 2006-06-05 2007-12-13 California Institute Of Technology Real time micro arrays
EP2041574B1 (en) * 2006-07-14 2016-11-16 The Regents of The University of California Cancer biomarkers and methods of use threof
WO2008073629A2 (en) * 2006-11-03 2008-06-19 Board Of Regents, The University Of Texas System Bifunctional predictors of cancer treatment sensitivity and resistance
EP2119469B1 (en) 2007-02-06 2014-05-14 Hisamitsu Pharmaceutical Co., Inc. Microneedle device for diagnosis of allergy
EP2130913A4 (en) 2007-03-05 2010-09-01 On Chip Cellomics Consortium CHIP FOR CELL COMPONENT SAMPLING, CELL COMPONENT ANALYSIS SYSTEM AND CELL COMPONENT ANALYSIS METHOD USING THEREOF
CA2686861A1 (en) * 2007-05-03 2008-11-13 Medimmune, Llc Interferon alpha-induced pharmacodynamic markers
EP2160472A1 (en) * 2007-06-04 2010-03-10 IN Situ RCP A/S Enzyme activity assay using rolling circle amplification
US8609041B2 (en) 2007-08-06 2013-12-17 Samir Mitragotri Apparatus for solubilizing tissue
WO2009023517A2 (en) 2007-08-10 2009-02-19 Wayne State University Compositions and methods for detecting and modulating cell death by a translation regulated gene expression system
KR101555391B1 (ko) 2007-11-21 2015-09-23 가부시키가이샤 바이오세렌택 체표 적용 제제 및 체표 적용 제제 보유 시트
WO2009140735A1 (en) * 2008-05-23 2009-11-26 The University Of Queensland Analyte detection by microneedle patch with analyte selective reagents.
WO2010031059A2 (en) 2008-09-15 2010-03-18 Deka Products Limited Partnership Systems and methods for fluid delivery
US8613937B2 (en) 2008-10-31 2013-12-24 The Invention Science Fund I, Llc Compositions and methods for biological remodeling with frozen particle compositions
WO2010101625A2 (en) 2009-03-02 2010-09-10 Seventh Sense Biosystems, Inc. Oxygen sensor
WO2010128158A1 (en) 2009-05-08 2010-11-11 Novartis Ag Diagnostic biomarkers for fibrotic disorders
EP2275164A1 (en) 2009-07-15 2011-01-19 Debiotech S.A. Multichannel micro-needles
RU2570280C2 (ru) 2010-04-28 2015-12-10 Кимберли-Кларк Ворлдвайд, Инк. Композитная матрица микроигл, содержащая на поверхности наноструктуры
US20110294996A1 (en) * 2010-05-31 2011-12-01 Scheiber Lane Bernard Quantum unit of inheritance
CN103261413B (zh) 2010-12-03 2015-09-16 株式会社益力多本社 三剂并用抗癌剂感受性判定标记
WO2014093934A1 (en) 2012-12-14 2014-06-19 Mindera Corporation Methods and devices for detection and acquisition of biomarkers

Also Published As

Publication number Publication date
WO2014093934A1 (en) 2014-06-19
JP7572774B2 (ja) 2024-10-24
JP2022177287A (ja) 2022-11-30
JP2025138775A (ja) 2025-09-25
AU2023204575B2 (en) 2025-07-10
KR102216949B1 (ko) 2021-02-22
HK1212932A1 (en) 2016-06-24
JP2024073562A (ja) 2024-05-29
KR20210020164A (ko) 2021-02-23
KR102378235B1 (ko) 2022-03-25
EP3542850A1 (en) 2019-09-25
JP2016509471A (ja) 2016-03-31
AU2023204575A1 (en) 2023-08-03
JP2019216746A (ja) 2019-12-26
KR20240091108A (ko) 2024-06-21
CA2892587A1 (en) 2014-06-19
CN104853802A (zh) 2015-08-19
AU2025248690A1 (en) 2025-10-30
AU2020239750B2 (en) 2023-04-20
US9540684B2 (en) 2017-01-10
CN104853802B (zh) 2021-12-07
AU2019201136A1 (en) 2019-03-07
EP2931356B1 (en) 2019-03-06
KR20220038832A (ko) 2022-03-29
EP2931356A1 (en) 2015-10-21
CN114176586B (zh) 2025-01-07
KR20150123788A (ko) 2015-11-04
US20170145489A1 (en) 2017-05-25
US20210317513A1 (en) 2021-10-14
US10995366B2 (en) 2021-05-04
US20140287942A1 (en) 2014-09-25
AU2019201136B2 (en) 2020-06-25
AU2013358890A1 (en) 2015-06-04
JP7704916B2 (ja) 2025-07-08
CN114176586A (zh) 2022-03-15
EP2931356A4 (en) 2016-08-24
AU2020239750A1 (en) 2020-10-22

Similar Documents

Publication Publication Date Title
CN114176586B (zh) 用于检测和获取生物标志物的方法和装置
Qi et al. Ultrasensitive point-of-care detection of protein markers using an aptamer-CRISPR/Cas12a-regulated liquid crystal sensor (ALICS)
HK40014889A (en) Methods and devices for detection and acquisition of biomarkers
HK1212932B (en) Methods and devices for detection and acquisition of biomarkers
Gomase et al. Physiomics
JP7653584B2 (ja) 膵管内乳頭状粘液性腫瘍由来膵癌または膵癌を検出する方法およびキット
EP4665869A1 (en) Methods and devices for using enzymatic amplification and fragmentation to detect biomarkers with nanopores
Al-Jaziri et al. The Role Of Laboratory Tests In Diagnosing Autoimmune Diseases
CN116875673A (zh) 一种诊断心肌梗死的系统
KR20200020160A (ko) 타액 프로토콜
EP1954835A4 (en) METHOD FOR THE PRESENTATION OF SIGNAL TRANSDUCTION PATHS ON GENE EXPRESSION PROGRAMS

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination